Stay updated on Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2 on the Record History page, with no observed changes to study data or page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T15:53:25.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page history now shows a new revision entry labeled v3.3.1, replacing the previous v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T12:10:47.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Removed a site-wide notice about government funding and operating status from the page. The notice was not specific to the trial record contents or data integrity. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-17T06:17:58.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The Old and New screenshots show the same historical versions list with no added or removed entries; the change appears to be a minor layout/visual adjustment. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T00:52:10.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Summary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.
    Difference
    10%
    Check dated 2025-10-05T07:41:04.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.
    Difference
    0.2%
    Check dated 2025-09-28T02:55:33.000Z thumbnail image

Stay in the know with updates to Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial page.